Annual CFI
$40.30 M
+$495.71 M+108.85%
31 December 2023
Summary:
Atea Pharmaceuticals annual cash flow from investing activities is currently $40.30 million, with the most recent change of +$495.71 million (+108.85%) on 31 December 2023. During the last 3 years, it has risen by +$40.33 million (+155111.54%). AVIR annual CFI is now at all-time high.AVIR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$122.01 M
-$246.70 M-197.86%
30 September 2024
Summary:
Atea Pharmaceuticals quarterly cash flow from investing activities is currently -$122.01 million, with the most recent change of -$246.70 million (-197.86%) on 30 September 2024. Over the past year, it has dropped by -$63.50 million (-108.52%). AVIR quarterly CFI is now -197.86% below its all-time high of $124.69 million, reached on 30 June 2024.AVIR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$87.25 M
-$63.50 M-42.12%
30 September 2024
Summary:
Atea Pharmaceuticals TTM cash flow from investing activities is currently $87.25 million, with the most recent change of -$63.50 million (-42.12%) on 30 September 2024. Over the past year, it has increased by +$41.23 million (+89.58%). AVIR TTM CFI is now -42.12% below its all-time high of $150.75 million, reached on 30 June 2024.AVIR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVIR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +108.8% | -108.5% | +89.6% |
| 3 y3 years | +10000.0% | -100.0% | +10000.0% |
| 5 y5 years | +10000.0% | - | - |
AVIR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +108.8% | -197.9% | +74.9% | -42.1% | +117.8% |
| 5 y | 5 years | at high | +108.8% | -197.9% | +74.9% | -42.1% | +117.8% |
| alltime | all time | at high | +108.8% | -197.9% | +74.9% | -42.1% | +117.8% |
Atea Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$122.01 M(-197.9%) | $87.25 M(-42.1%) |
| June 2024 | - | $124.69 M(+119.5%) | $150.75 M(+107.6%) |
| Mar 2024 | - | $56.80 M(+104.5%) | $72.63 M(+80.2%) |
| Dec 2023 | $40.30 M(-108.8%) | $27.77 M(-147.5%) | $40.30 M(-12.4%) |
| Sept 2023 | - | -$58.51 M(-225.7%) | $46.02 M(-112.0%) |
| June 2023 | - | $46.56 M(+90.2%) | -$382.44 M(-11.2%) |
| Mar 2023 | - | $24.48 M(-26.9%) | -$430.89 M(-5.4%) |
| Dec 2022 | -$455.41 M | $33.49 M(-106.9%) | -$455.41 M(-6.9%) |
| Sept 2022 | - | -$486.98 M(>+9900.0%) | -$488.90 M(>+9900.0%) |
| June 2022 | - | -$1.88 M(+4170.5%) | -$1.93 M(+3914.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$44.00 K(+1000.0%) | -$48.00 K(+1100.0%) |
| Dec 2021 | -$4000.00(-84.6%) | -$4000.00(<-9900.0%) | -$4000.00(-20.0%) |
| Sept 2021 | - | $0.00(0.0%) | -$5000.00(-75.0%) |
| June 2021 | - | $0.00(0.0%) | -$20.00 K(-23.1%) |
| Mar 2021 | - | $0.00(-100.0%) | -$26.00 K(0.0%) |
| Dec 2020 | -$26.00 K(+1200.0%) | -$5000.00(-66.7%) | -$26.00 K(+23.8%) |
| Sept 2020 | - | -$15.00 K(+150.0%) | -$21.00 K(+250.0%) |
| June 2020 | - | -$6000.00(<-9900.0%) | -$6000.00(<-9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | -$2000.00(-83.3%) | - | - |
| Dec 2018 | -$12.00 K | - | - |
FAQ
- What is Atea Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual CFI year-on-year change?
- What is Atea Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly CFI year-on-year change?
- What is Atea Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals TTM CFI year-on-year change?
What is Atea Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AVIR is $40.30 M
What is the all time high annual CFI for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual cash flow from investing activities is $40.30 M
What is Atea Pharmaceuticals annual CFI year-on-year change?
Over the past year, AVIR annual cash flow from investing activities has changed by +$495.71 M (+108.85%)
What is Atea Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AVIR is -$122.01 M
What is the all time high quarterly CFI for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly cash flow from investing activities is $124.69 M
What is Atea Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AVIR quarterly cash flow from investing activities has changed by -$63.50 M (-108.52%)
What is Atea Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AVIR is $87.25 M
What is the all time high TTM CFI for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high TTM cash flow from investing activities is $150.75 M
What is Atea Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AVIR TTM cash flow from investing activities has changed by +$41.23 M (+89.58%)